Adam Rubenstein, and his excellent website, OnBioVC
, are one of the best sources for understanding the flow of Venture Capital, and Mergers & Acquisitions in the bioscience space including analysis of dealflow, regional distribution and sectors - Biopharma, Diagnostics, Devices, Medical-IT and Biofuels .. It is a lot of information, but for those trying to understand how to fund medical technology ... priceless!
Hot off the press! The 2Q10 OnBioVC Trend Analysis
is available (attached) or via download [HERE
]; and features OnBioIPO and OnBioM&A data too!
The 2Q10 OnBioVC Trend Analysis tracked, in aggregate, 81 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,664.2M. Compared to 1Q10 OnBioVC data, this investment activity represents an increase in the number of quarter-versus-quarter financings by 7 (81 v. 74) and an increase in quarter-versus-quarter invested capital of $404.1M ($1,664.2M v. $1,260.0M).
Please share this 2Q10 Trend Analysis with your friends and colleagues.
Give the gift of sharing...it would be very much appreciated!
Recall, if you wish to receive the daily OnBioVC missive delivered to your inbox or RSS feed then please sign up under "subscription options" in the upper right of http://OnBioVC.com
Many thanks to our wonderful partners who make OnBioVC possible. Please show them your support!
Sign up [HERE] for FREE Subscriptions to 'Pharmaceutical Executive' and 'Life Science Leader' Magazines (and other journals